ES2036809T3 - Variantes de la hirudina, sus utilizaciones y los procedimientos para obtenerlas. - Google Patents

Variantes de la hirudina, sus utilizaciones y los procedimientos para obtenerlas.

Info

Publication number
ES2036809T3
ES2036809T3 ES198989400621T ES89400621T ES2036809T3 ES 2036809 T3 ES2036809 T3 ES 2036809T3 ES 198989400621 T ES198989400621 T ES 198989400621T ES 89400621 T ES89400621 T ES 89400621T ES 2036809 T3 ES2036809 T3 ES 2036809T3
Authority
ES
Spain
Prior art keywords
hirudine
variants
procedures
improve
order
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989400621T
Other languages
English (en)
Inventor
Michael Courtney
Eric Degryse
Gerard Loison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Application granted granted Critical
Publication of ES2036809T3 publication Critical patent/ES2036809T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Removal Of Specific Substances (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

VARIANTES DE HIRUDINA CREADAS ARTIFICIALMENTE CON EL FIN DE MEJORAR SUS PROPIEDADES FARMACEUTICAS.
ES198989400621T 1988-03-08 1989-03-06 Variantes de la hirudina, sus utilizaciones y los procedimientos para obtenerlas. Expired - Lifetime ES2036809T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8802925A FR2628429B1 (fr) 1988-03-08 1988-03-08 Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir

Publications (1)

Publication Number Publication Date
ES2036809T3 true ES2036809T3 (es) 1993-06-01

Family

ID=9364012

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989400621T Expired - Lifetime ES2036809T3 (es) 1988-03-08 1989-03-06 Variantes de la hirudina, sus utilizaciones y los procedimientos para obtenerlas.

Country Status (10)

Country Link
US (1) US5087613A (es)
EP (1) EP0332523B1 (es)
JP (1) JP2961118B2 (es)
AT (1) ATE84571T1 (es)
CA (1) CA1341429C (es)
DE (1) DE68904330T2 (es)
ES (1) ES2036809T3 (es)
FR (1) FR2628429B1 (es)
GR (1) GR3007254T3 (es)
PT (1) PT89923B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8907110D0 (en) * 1988-05-04 1989-05-10 Ciba Geigy Ag Improvements in the production of polypeptides
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
FR2646437B1 (fr) * 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
EP0502962B1 (de) * 1989-12-01 1996-03-13 BASF Aktiengesellschaft Hirudin-Muteine und deren Polyalkylenglykolkonjugate
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) * 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
ZA915658B (en) * 1990-07-24 1992-05-27 Merrell Dow Pharma Analogs of hirudin having antiplatelet activity
EP0540574B1 (en) * 1990-07-24 1996-09-11 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
GB9023149D0 (en) * 1990-10-24 1990-12-05 British Bio Technology Proteins and nucleic acids
US5837808A (en) * 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
WO1993004082A1 (en) * 1991-08-20 1993-03-04 Baxter International Inc. Analogs of hirudin
GB9209032D0 (en) * 1992-04-25 1992-06-10 Ciba Geigy Ag New peptide derivatives
EP0702696B1 (en) * 1993-06-11 2003-07-30 Merrell Pharmaceuticals Inc. Trifunctional antithrombin and antiplatelet peptides
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
US8377863B2 (en) * 2007-05-29 2013-02-19 Unigene Laboratories Inc. Peptide pharmaceutical for oral delivery
JP6910950B2 (ja) 2015-01-12 2021-07-28 エンテリス・バイオファーマ・インコーポレイテッドＥｎｔｅｒｉｓ Ｂｉｏｐｈａｒｍａ，Ｉｎｃ． 固形経口剤形

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341414C (fr) * 1984-03-27 2002-12-31 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens
FR2607517B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu

Also Published As

Publication number Publication date
ATE84571T1 (de) 1993-01-15
US5087613A (en) 1992-02-11
GR3007254T3 (es) 1993-07-30
JP2961118B2 (ja) 1999-10-12
PT89923A (pt) 1989-11-10
FR2628429A1 (fr) 1989-09-15
JPH029390A (ja) 1990-01-12
DE68904330T2 (de) 1993-05-19
EP0332523A1 (fr) 1989-09-13
EP0332523B1 (fr) 1993-01-13
PT89923B (pt) 1994-05-31
DE68904330D1 (de) 1993-02-25
CA1341429C (fr) 2003-05-27
FR2628429B1 (fr) 1990-12-28

Similar Documents

Publication Publication Date Title
ES2036809T3 (es) Variantes de la hirudina, sus utilizaciones y los procedimientos para obtenerlas.
ES2061512T3 (es) Polipeptidos de nor-estatina y nor-cicloestatina.
ES522085A0 (es) Procedimiento para producir t-p-a humano activador de plasminogeno.
SE8501709D0 (sv) Improvements in or relating to intrleukin therapy
ES2024462B3 (es) Terpolimeros su aplicacion en acondicionadores para el cabello y acondicionadores que los contienen.
IT1126452B (it) Testa di estrusione per profilati per infissi e simili,nonche' profilato ottenuto
MX9100032A (es) Procedimiento para preparar fenoxialquilisoxazoles y furanos substituidos heterociclicos.
TR23086A (tr) Yueksek dikkat cekici karayolu isareti
IT1003526B (it) Dispositivo per la produzione continua di pannelli di trucioli o simili
GR1000318B (el) Θεραπευτικως δραστικη υποκατεστημενη βενζιμιδαζολη και μεθοδος για την παρασκευη αυτης.
ES2168276T3 (es) 1-arilsulfonil-3-fenil-1,4,5,6-tetrahidropiridazinas.
ES2193248T3 (es) Antraquinonas mono- y disulfosustituidas y su uso para el tratamiento de desordenes de la matriz osea.
FI854074L (fi) Peptid-substituerade heterocykliska immunostimulanter.
IT8620970A0 (it) Eteri 5,6-epossi-7-ossabicicloeptano sostituiti utili nel trattamento di trombosi.
IT1204414B (it) Analoghi di amminoprostaglandine 5,6-epossi-7-ossabicicloeptano sostituite,utili nel trattamento di trombosi
RO72151A (ro) Explozivi sub forma de gel spumati,stabilizati
DK610287A (da) Peptider, deres fremstilling og anvendelse
ES554843A0 (es) Procedimiento selectivo para la preparacion del isosorbido-5-mononitrato
IT1188704B (it) Derivati insaturi cicloalifatici,loro procedimenti di prepatazione e loro impiego in terapia e in cosmetica
IT1000301B (it) Perfezionamento negli accendisi gari e simili
ES2061052T3 (es) Monohidrocloruro y monometanolsulfonato de amonafide.
TR22461A (tr) Aluminyum fosfinat-amin katilma ueruenleri,ve bunlarin ueretimi ve kullanimi
FR2358403A1 (fr) Nouveaux 2-imino-1,3-benzodithiolannes utiles notamment comme anti-inflammatoires
IT974241B (it) Procedimento per la produzione di formammidine n 2 ciano 4 nitrofenil n nbisostituite e formammidine n 2 ciano 6 nitrofenil n n bisosti tuite
DK0484331T3 (da) Enkeltkrystaller af -g(b)-phenylpropiophenoner

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 332523

Country of ref document: ES